Cellworks Biosimulation Platform and computational biology omics model (CBM) is advancing Personalized Oncology through patient-specific cancer therapy predictions. Cellworks informative drug response predictions empower physicians to provide personalized therapy selection and improve patient outcomes. Cellworks therapy biosimulation technology goes beyond the current ‘one mutation, one drug’ paradigm by interpreting complete mutational downstream effects to deliver precise and transparent therapy predictions. Join the Cellworks myCare clinical trials today.